From January 1, 2022 to March 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 3,250,193 shares, representing 3.23% for $12 million under the buyback announced on November 4, 2020.
BioDelivery Sciences International, Inc.
Equities
BDSI
US09060J1060
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+25.77% | 661B | |
+26.74% | 566B | |
-6.73% | 352B | |
+18.77% | 332B | |
+3.20% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.43% | 145B |